Jubilant Life Sciences is planning to raise funds up to an amount of Rs 750 crore by issuance of Non-Convertible Debentures (NCDs). The meeting of the Board of Directors of the company is scheduled to be held on June 27, 2018, to consider the same.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.